Identification of NanoLuciferase Substrates Transported by Human ABCB1 and ABCG2 and their Zebrafish Homologs at the Blood-Brain Barrier
Collin T. Inglut(National Institutes of Health), Michael M. Gottesman(National Institutes of Health)
Cited by 0
Related Papers
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
|Pharmacological Reviews|2012|968
Immunological and Toxicological Considerations for the Design of Liposomes
|Nanomaterials|2020|357
Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells
|Cancer Letters|2019|60
Overlapping Substrate and Inhibitor Specificity of Human and Murine ABCG2
|Drug Metabolism and Disposition|2013|49